Elapegademase
CAS 1709806-75-6Biologic
Overview
Elapegademase is a recombinant pegylated enzyme indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID). It replaces the function of the deficient or malfunctioning ADA enzyme in patients.
Therapeutic areas
Genetic Disorders
Verified Supplier Partner
Do you supply Elapegademase? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.